MedTrace Logo

kTMP in Chronic Stroke

NCT07277595 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-05-06

No results posted yet for this study

Summary

kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.

Conditions

  • Stroke
  • Chronic Stroke Patients
  • Arm Weakness as a Consequence of Stroke

Interventions

DEVICE

kTMP sham stimulation 9 weeks + active stimulation 9 weeks

kTMP 9 weeks sham-kTMP stimulation, followed by 9 weeks active kTMP stimulation

DEVICE

kTMP 18 weeks

Participants receive kTMP active stimulation for 18 weeks

Sponsors & Collaborators

Principal Investigators

  • Karunesh Ganguly, MD, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2030-08-01
Completion
2030-08-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07277595 on ClinicalTrials.gov